News

Balt receives IDE approval from the FDA to begin the STEM Trial

Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma.

Discover the Press Release

Other News

News
Apr 14, 2025

TJ Miller, Comedian/Actor & An arteriovenous malformation (AVM) Survivor, Featured in NeuroNews

Read More
Balt
News
Feb 06, 2025

Balt featured at the “Annales des Mines”

Read More
Balt featured at the “Annales des Mines”
News
Feb 05, 2025

Balt is hiring!

Read More
Balt
News
Dec 20, 2024

Balt secures €355 million to refinance its debt and accelerate its growth

Read More
Balt
News
Nov 22, 2024

STEM trial results in the New England Journal of Medicine (NEJM)

Read More
STEM trial results in the New England Journal of Medicine (NEJM)
News
Oct 13, 2024

Balt at the 20km de Paris

Read More
Balt at the 20km de Paris
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.

EN